Diagnostic accuracy of plasma calprotectin and serum calprotectin in patients with suspected Crohn's disease

被引：0
|
作者：
Rasmussen, M. H. [1 ]
Brodersen, J. B. [1 ]
Brasen, C. L. [2 ]
Madsen, J. S. [2 ]
Knudsen, T. [1 ]
Kjeldsen, J. [3 ]
Jensen, M. D. [1 ]
机构：
[1] Univ Hosp Southern Denmark, Dept Internal Med, Hosp South West Jutland, Sect Gastroenterol, Esbjerg, Denmark
[2] Univ Hosp Southern Denmark, Dept Clin Biochem & Immunol, Lillebaelt Hosp, Vejle, Denmark
[3] Odense Univ Hosp, Dept Med Gastroenterol, Odense, Denmark
来源：
JOURNAL OF CROHNS & COLITIS | 2024年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P317
引用
收藏
页码：I691 / I693
页数：3
相关论文
共 50 条
  • [31] Faecal calprotectin: a new marker for Crohn's disease?
    Wassell, J
    Dolwani, S
    Metzner, M
    Losty, H
    Hawthorne, A
    ANNALS OF CLINICAL BIOCHEMISTRY, 2004, 41 : 230 - 232
  • [32] Primary care faecal calprotectin testing in children with suspected inflammatory bowel disease: a diagnostic accuracy study
    Walker, Gareth J.
    Chanchlani, Neil
    Thomas, Amanda
    Lin, Simeng
    Moore, Lucy
    Heerasing, Neel M.
    Hendy, Peter
    Abdelrahim, Mohamed
    Mole, Sean
    Perry, Mandy H.
    Mcdonald, Timothy J.
    Bewshea, Claire M.
    Hart, James W.
    Russell, Richard K.
    Ahmad, Tariq
    Goodhand, James R.
    Kennedy, Nicholas A.
    ARCHIVES OF DISEASE IN CHILDHOOD, 2020, 105 (10) : 957 - +
  • [33] Serum calprotectin (MRP8/14) is not a predictor of relapse in Crohn's disease
    Bitton, A
    Roth, J
    Edwardes, MD
    Fortin, G
    Cohen, A
    Villani, C
    Steinfeld, S
    Wild, G
    Franchimont, D
    GASTROENTEROLOGY, 2005, 128 (04) : A307 - A307
  • [34] Fecal calprotectin is an effective marker of disease activity in patients with ileal Crohn's disease
    Picardo, S.
    So, K.
    Venugopal, K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 140 - 141
  • [35] Utility of faecal calprotectin to assess Crohn's disease activity in patients with an ileostomy
    Rowan, C. R.
    Alzubi, S.
    Healy, M.
    Cullen, G.
    Mulcahy, H.
    Sheridan, J.
    Doherty, G. A.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S268 - S268
  • [36] UTILITY OF FAECAL CALPROTECTIN TO ASSESS CROHN'S DISEASE ACTIVITY IN PATIENTS WITH AN ILEOSTOMY
    Rowan, Catherine
    Alzubi, Shabib
    Healy, Maeve
    Cullen, Garret
    Mulcahy, Hugh E.
    Sheridan, Juliette
    Doherty, Glen A.
    GASTROENTEROLOGY, 2018, 154 (06) : S397 - S397
  • [37] Clinical value of fecal calprotectin for evaluating disease activity in patients with Crohn′s disease
    Li, Junrong
    Xu, Mingyang
    Qian, Wei
    Ling, Fangmei
    Chen, Yidong
    Li, Shuang
    Cheng, Yiyu
    Zhu, Liangru
    FRONTIERS IN PHYSIOLOGY, 2023, 14
  • [38] Stomal calprotectin as a biomarker for assessing Crohn's disease activity in patients with stomas
    Abeyratne, Kavindra
    Harb, Martin
    Bensted, Karen
    Ghaly, Simon
    Connor, Susan J.
    Andrews, Jane M.
    Lynch, Kate D.
    INTERNAL MEDICINE JOURNAL, 2025, 55 (03) : 461 - 466
  • [39] Levels of Fecal Calprotectin and the Severity of Postoperative Patients With Crohn's Disease Response
    Boschetti, Gilles
    Drai, Jocelyne
    Flourie, Bernard
    Nancey, Stephane
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 (08): : 1242 - 1242
  • [40] Faecal calprotectin and plasma cytokines in the prediction of early postoperative Crohn's disease recurrence
    Cerrillo, E.
    Moret, I.
    Iborra, M.
    Hervas, D.
    Tortosa, L.
    Saez-Gonzalez, E.
    Nos, P.
    Beltran, B.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S257 - S257
12345